Compass Therapeutics to Participate in Upcoming Investor Events
30 Agosto 2023 - 2:00PM
Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage,
oncology-focused biopharmaceutical company developing proprietary
antibody-based therapeutics to treat multiple human diseases, today
announced that the Company will participate in the following
investor events during the month of September 2023.
Details are as follows:
Citi’s 18th
Annual BioPharma Conference
Location: Boston, MAFormat: 1x1
MeetingsDate: Thursday, September 7
H.C. Wainwright
25th Annual Global Investment
Conference Location: New York, NY
Format: Presentation Date:
Monday, September 11Time: 4:00 PM ET
Webcast Link: https://journey.ct.events
Cantor Fitzgerald Global Healthcare
Conference Location: New York, NY
Format: Fireside Chat Date:
Wednesday, September 27Time: 2:25-2:55 PM ET
Webcast Link:
https://wsw.com/webcast/cantor19/cmpx
Virtual/Replay
availability: Presentations will be archived for 90
days on Compass’ Events page.
About Compass TherapeuticsCompass Therapeutics,
Inc. is a clinical-stage oncology-focused biopharmaceutical company
developing proprietary antibody-based therapeutics to treat
multiple human diseases. Compass’ scientific focus is on the
relationship between angiogenesis, the immune system, and tumor
growth. The company pipeline of novel product candidates is
designed to target multiple critical biological pathways required
for an effective anti-tumor response. These include modulation of
the microvasculature via angiogenesis-targeted agents, induction of
a potent immune response via activators on effector cells in the
tumor microenvironment, and alleviation of immunosuppressive
mechanisms used by tumors to evade immune surveillance. Compass
plans to advance its product candidates through clinical
development as both standalone therapies and in combination with
proprietary pipeline antibodies based on supportive clinical and
nonclinical data. The company was founded in 2014 and is
headquartered in Boston, Massachusetts. For more information, visit
the Compass Therapeutics website
at https://www.compasstherapeutics.com.
Investor Contactir@compasstherapeutics.com
Media ContactAnna Gifford, Communications
Managermedia@compasstherapeutics.com 617-500-8099
Grafico Azioni Compass Therapeutics (NASDAQ:CMPX)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Compass Therapeutics (NASDAQ:CMPX)
Storico
Da Giu 2023 a Giu 2024